Back

Pharmacological MALT1 inhibition ameliorates cardiac inflammation and dysfunction in experimental autoimmune myocarditis

11 May 2026 (12:30 - 13:15)
Organised by: Logo
Congress Presentation Part of: New insights from animal models of heart failure and cardiomyopathy Cardiac Diseases HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Anca Remes

Christian-Albrechts-University Kiel, Kiel (Germany)

4 More presentations in this session

Presentation thumbnail
Glucose-independent effects of empagliflozin on gap junction and extracellular matrix remodeling in volume overload heart failure
Doctor M. Sykora (Bratislava, SK)
Abstract Slides
Presentation thumbnail
Integrated multi-omics reveals epigenetic control of renal damage in HFpEF
Miss N. Atzemian (Zurich, CH)
Abstract Slides
Presentation thumbnail
Involvement of connexin 43 in brown adipose tissue dysfunction in type 2 diabetes
Doctor T. Egan Benova (Bratislava, SK)
Abstract Slides
Presentation thumbnail
The role of mitochondrial respiratory pathways using different cardioplegic solutions in immature rat hearts: a comparative study on moderate and prolonged ischemic periods
Mr D. Verikas (Kaunas, LT)
Abstract Slides

Access the full session

Session thumbnail
New insights from animal models of heart failure and cardiomyopathy

The Event

Event poster

Heart Failure 2026

11 May 2026 12:30 CET
You may be interested in
thumbnail
ESC TV Today
Episode 15: Colchicine for secondary prevention - An algorithmic approach to the workup of syncope
thumbnail
Congress Session
When time is the issue
thumbnail
Congress Session
Clinical cases session

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources